1. Frerichs H, Track NN (1974) Pharmacotherapy of hormone secreting tumours. Clin Gastroenterol 3: 721–732
2. Stöckmann F, Creutzfeldt W (1988) Behandlung gastrointestinaler neuroendokriner Tumoren mit dem Somatostatin-Analog Octreotide (Sandostatin) . Z Gastroenterol 26: 665–675
3. Murray-Lyon JM, Eddleston ALWF, Williams R et al. (1968) Treatment of a multiple-hormone-producing malignant isletcell tumour with streptozotocin. Lancet II: 895–898
4. Junge U, Creutzfeldt W (1985) Endokrine Tumoren des Gastrointestinaltraktes. In: Gross R, Schmidt CG (Hrsg) Klinische Onkologie. Thieme, Stuttgart München New York, S 29.0–29.17
5. Moertel CG, Hanley JA, Johnson LA (1980) Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 303: 1189–1194